Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ION-260

Home DrugsION-260

ION-260

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Traditional Chinese medicine ointment capable of tonifying qi, nourishing blood, strengthening bones, promoting blood circulation, stopping pain, detoxifying and repelling cold
CN 102935124 AApplicant: LIU XUEMEIPriority: 2012
CN
Traditional Chinese medicine preparation for external treatment of cold-dampness arthralgia
CN 105362919 AApplicant: WEI YONGZHONGPriority: 2014
CN
GC-MS analysis method for volatile components in red and green fresh leaves of partridge tea
CN 109541073 AApplicant: UNIV HAINANPriority: 2019
CN
Composition for repairing cervix uteri and preventing bacterial vaginitis
CN 115708858 AApplicant: GUANGZHOU DEXIN NETWORK SERVICE CO LTDPriority: 2021
CN
Liquid medicine for treating bronchial asthma and administration device thereof
CN 117919258 AApplicant: ZHOU ZIDONGPriority: 2024
CN
1,3-BUTYLENE GLYCOL PRODUCT
WO 2026018556 A1Applicant: DAICEL CORPPriority: 2024
WO